Cowen & Company Initiates Coverage on Diplomat Pharmacy Inc to Market Perform

Cowen & Company Initiates Coverage on Diplomat Pharmacy Inc(NYSE:DPLO). The shares have been rated Market Perform. The rating by Cowen & Company was issued on Jun 24, 2016.

In a different note, On Jun 7, 2016, Bank of America said it Reinstates its rating on Diplomat Pharmacy Inc. The shares have been rated ‘Neutral’ by the firm. Avondale Partners said it Initiates Coverage on Diplomat Pharmacy Inc, according to a research note issued on Apr 18, 2016. The shares have been rated ‘Market Outperform’ by the firm.

Diplomat Pharmacy Inc (DPLO) made into the market gainers list on Wednesdays trading session with the shares advancing 2.74% or 0.93 points. Due to strong positive momentum, the stock ended at $34.92, which is also near the day’s high of $35.18. The stock began the session at $34.35 and the volume stood at 2,86,851 shares. The 52-week high of the shares is $52.3324 and the 52 week low is $22.41. The company has a current market capitalization of $2,304 M and it has 6,59,77,282 shares in outstanding.

Diplomat Pharmacy Inc(DPLO) last announced its earnings results on May 9, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $995.87M. Analysts had an estimated revenue of $982.87M. Earnings per share were $0.23. Analysts had estimated an EPS of $0.18.

Several Insider Transactions has been reported to the SEC. On Jun 2, 2016, Atheer A Kaddis (EVP of Sales & Strategic Align) sold 12,325 shares at $32.37 per share price.Also, On Dec 8, 2015, Philip R Hagerman (Chairman and CEO) sold 2,300,000 shares at $33.60 per share price.On Dec 2, 2015, Gary W Kadlec (President) sold 30,000 shares at $35.08 per share price, according to the Form-4 filing with the securities and exchange commission.

Diplomat Pharmacy Inc. (Diplomat) is an independent specialty pharmacy in the United States. The Company provides specialty pharmacy support services to a national network of retailers and independent pharmacy groups hospitals and health systems. The Company offers services in Specialty Drug Dispensing which includes its specialty infusion pharmacy services. The specialty drug dispensing services include Patient Care Coordination Clinical Services Compliance and Persistency Programs Patient Financial Assistance Specialty Pharmacy Training/Consulting (Diplomat University) Benefits Investigation Prior Authorization Risk Evaluation and Medication Strategy (REMS) Retail Specialty Services Hospital and Health System Services and Hub Services. The Company help patients adhere to complicated medication therapies process refills and manage any side effects and insurance concerns to ensure they get the standard of care.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Diplomat Pharmacy Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Diplomat Pharmacy Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.